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ABSTRACT: In this paper, we introduce the BiKi Life Sciences suite. This
software makes it easy for computational medicinal chemists to run ad hoc
molecular dynamics protocols in a novel and task-oriented environment; as a
notebook, BiKi (acronym of Binding Kinetics) keeps memory of any activity
together with dependencies among them. It oﬀers unique accelerated protein−
ligand binding/unbinding methods and other useful tools to gain actionable
knowledge from molecular dynamics simulations and to simplify the drug discovery
process.
■ INTRODUCTION
Computational chemistry has played an increasingly central
role in drug discovery and pharmaceutical research, becoming
an established tool in the search for novel bioactive
compounds.1 Compared to other computational methods,
molecular dynamics (MD) has, until recently, played a marginal
role in prospective drug discovery projects, especially those
carried out in industry. Three elements have hampered the
widespread exploitation of MD for pharmaceutical research.
First, MD has traditionally been perceived as a simulative
technique that is diﬃcult to implement and automatize because
it relies on a complex theoretical background. Second, the
analysis of long MD trajectories can be a daunting task that
ultimately fails to return clear and speciﬁc insights into how to
design and synthesize new and more eﬀective compounds.
Finally, MD is regarded as very time-consuming and therefore
incompatible with the stringent time requirements of most drug
discovery projects.
Recently, thanks to the advent of novel hardware
architectures, including graphical processor units (GPUs) and
purposely designed machines,2 and the development of
innovative algorithms,3 it is becoming possible to compute
MD trajectories of pharmaceutically relevant systems on a time
scale approaching that of biological events. Some published
studies have used plain MD simulations, encompassing several
microsecond-long trajectories, to investigate the spontaneous
binding of ligands to their biological counterparts.4−6 However,
such studies are still very computationally demanding, even for
one single compound, which drastically limits their applicability.
Furthermore, some events, including the spontaneous unbind-
ing of molecules with long residence times, are still beyond the
reach of plain MD simulations even in combination with
purpose-built hardware architectures. To overcome these
limitations, several physical approaches aimed at enhancing
the sampling of rare events have been developed over the last
20 years.1 These advanced sampling schemes7 may have
addressed the issue of speed. However, the applicability of MD
and related methods is still limited by diﬃculties in simulation
setup and analysis, particularly when dealing with accelerated
sampling prospectively applied to drug discovery projects. We
recently developed several speciﬁc dedicated algorithms for
fully ﬂexible dynamic docking3 and undocking.8,9 These
algorithms require a limited number of free parameters, thus
transforming valuable but previously impractical algorithms into
a new technology, which can be exploited by a wider
community of users in industry and academia. Here, we report
on a new software suite, named BiKi Life Sciences: this suite
includes the above algorithms via a set of modules in a coherent
graphical and scripting environment aimed at facilitating the
use of MD in drug discovery with particular focus to the hit-to-
lead and lead optimization phases.
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■ BIKI LIFE SCIENCES
BiKi Life Sciences (hereafter referred to as BiKi, acronym of
Binding Kinetics) is an integrated software environment,
encompassing multiple modules:
• BiKi Basic, a core module dedicated to setting up classic
MD simulations and related postprocessing and analysis
methods;
• BiKi Netics to study unbinding kinetics via scaled MD
simulations;8
• Pocketron for a dynamical analysis of MD trajectories in
order to characterize pockets and potential binding sites
and identify the allosteric connections between them;10
• BiKi MD-Binding for a fully solvated and dynamic
docking based on a purpose-built bias;3
• BiKi Hydra to assess the relevance of water molecules
within binding pockets based on their stability.11
The functions of each module can be accessed through a
graphical user interface (GUI) or through the BiKi scripting
engine. Figure 1 reports a schematic summary of the BiKi
modules and their interactions. The BiKi GUI is written in Java
and is built around the concept of “project”. Each project has a
one-to-one correspondence with a folder on disk and comprises
a set of simulation and analysis items, together with input/
output ﬁles. The BiKi scripting engine is an API coded in Java.
It allows the functionalities oﬀered by the GUI to be replicated
in more detail. In particular, this API allows scripting in Python,
through the system interpreter, or leveraging the internal
Groovy interpreter. Both the GUI and the scripting engine are
interfaced with high-performance parallel codes (C, C++,
Fortran), partly developed by third parties such as plumed.12
A common aspect to all modules is that, for any selectable
item, BiKi automatically provides default values representative
of the corresponding typical simulative MD scenario. Often,
these parameters reﬂect a trade-oﬀ between accuracy and
execution speed. To make it more user-friendly for beginners,
only a limited number of tunable parameters are usually
displayed, while the rest can be found under the “advanced”
tab.
Each project comprises diﬀerent simulations. In turn, each
simulation comprises multiple simulation items. Items are
“stateful” objects that are stored inside a project. BiKi has also
some utilities for one-shot activities not logically linked to a
speciﬁc project. These are stateless objects that address speciﬁc
tasks.
Items, identiﬁed by the .bkx extension, are XML ﬁles that
store all the settings related to that speciﬁc aspect of the
simulation. Examples of items include the following: structures
ﬁles, periodic boxes, and input protocols. The name of every
item can be customized by the user, allowing long-term
traceability of any action.
A graphical project tree displays a project. All items pertinent
to a project are located under the “Setting” leaf. Two more
leaves are dedicated to input and output ﬁles (the “Input” and
“Output” leaves, respectively). Objects can depend on each
other through ﬁles, and in MD campaigns, structures are often
manipulated in a complex ﬂow. Therefore, BiKi has a built-in
dependency-resolution system. The dependency between ﬁles
coherently takes into account ﬁle changes as in a tool like
“make”. If an item/ﬁle depends on a ﬁle/item that has changed,
then the item must be updated according to the contents of the
modiﬁed ﬁle to restore consistency. This dependency
mechanism is transparent to the user.
■ BIKI BASICS
BiKi Basic can be used to perform all the relevant operations
related to setting up, running, and analyzing plain MD
trajectories. It is also the backbone on which the other modules
have been developed.
For the MD simulation setup, BiKi Basic provides the
following items/utilities:
• Pdb processing. PDB fetching, subselections with a
VMD-like syntax,13 residue manual protonation assign-
ment, automated water-naming conversion, axis align-
ment, duplicated atoms removal, conversion to pqr/xyzr,
chain termination, application of Amber naming
conventions, and hydrogen-adding for proteins.
• Molecule parameterization. An essential component of
the BiKi pipeline is the tool for parametrizing arbitrary
molecules (e.g., ligands). For BiKi, the Amber force ﬁeld
is the reference force ﬁeld and nomenclature. Therefore,
it interfaces to AmberTools to place water molecules and
to support charge computation.14 Currently, BiKi
supports ﬀ99SBildn15 and ﬀ14SB.16 Molecules can be
parametrized by a speciﬁc module that uses the general
Amber force ﬁeld (GAFF)17 and Antechamber.18 Newly
generated topologies can be stored in a local user library.
Residues parametrized outside BiKi can be imported and
added to the same library. RESP charge calculation is
supported via a BiKi speciﬁc interface to the NwChem
software.19 Since NwChem is not currently compatible
with Antechamber, BiKi provides a user-transparent
conversion tool that converts the NwChem output into
an Antechamber-compliant ESP ﬁle.
• Protein membrane embedding. The setup of a protein−
membrane simulation involves two steps: (i) predicting
the position/orientation of the protein within the bilayer
and (ii) the actual plugging of the protein within the
membrane lipids. BiKi’s membrane setup tool is devised
Figure 1. BiKi modules and their interactions: (yellow) builder
modules, (blue) analysis modules.
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to automate the entire procedure. The posing algorithm
works in a way similar to that deﬁned in the work of Wolf
et al.20 A relevant exception is that our score is calculated
according to a slightly modiﬁed approach. While BiKi
still computes a “per slice” partial score based on the
detection of a hydrophobic belt, we use an atomic-level
description to deﬁne the score. We adopt an
optimization procedure based on multiple cycles, again
in line with the work of Wolf et al.,20 where bisection
steps are used to converge to a local maximum.
The second phase is the actual plugging of the protein
into the membrane. The protein must be inserted while
causing the least perturbation possible in the already
equilibrated membrane template. To this end, in line
with the work of Yesylevskyy,21 BiKi generates a shrunk,
nonphysical version of the protein around its main
inertial axis. Using the values for shift and tilt obtained
during the posing phase, the shrunk protein is lodged in
the membrane, carving an initial hole in the bilayer by
removing all the lipids and water molecules within 3 Å of
the protein. The initial plugging can thus be carried out
while minimizing the number of lipids removed. Then,
several subsequent inﬂation steps gradually restore the
protein to its original size. At each step, the protein
structure is frozen while the protein−membrane
interaction potential is minimized. The protein internal
energy is ignored until the very last step, where the entire
protein structure is harmonically restrained and relaxed.
Alterations in local pressure can actually take place, but
they can easily be ﬁxed in the subsequent NPT
anisotropic equilibration phase. BiKi ships with a set of
pre-equilibrated membrane templates (users can store
their own customized templates, such as those built via
CharmmGUI,22 to an internal membrane template
database). Internal solvation is recovered via a purposely
developed strategy: (i) we compute the solvent excluded
surface (SES) of the protein via NanoShaper;23,24 (ii) we
solvate the protein structure; (iii) we discard all waters
except those internal to the SES, which are added to the
ﬁnal protein−membrane system. Final poses were
validated by comparison with structures in the OPM
database25 (see the SI).
• Molecule placement. When initializing molecular
dynamics runs, it is often the case that some molecules
must be placed at given positions, either in the solvent or
in predetermined sites of a protein. This item allows, for
instance, a ligand to be positioned in place of one
without hydrogens, or randomly into the solvent.
Another function, is the possibility to automatically
place the ligand in front of the targeted binding pocket
for the subsequent application of the MD binding
protocol. See ref 3 for more details.
• Simulation box setup. Once the molecules have been
parametrized if needed, the membrane has been included
in the system, and the other molecules have been placed,
the system topology can be assembled. At this stage, it is
assumed that the structure is complete and there are no
missing residues or atoms. The box/topology building
tool supports Amber topology ﬁles. These can later be
converted into Gromacs topologies, if needed. In this
way, BiKi indirectly supports multiple MD engines
including Amber,14 Namd,26 and Gromacs.27
• Simulation Protocol. Before performing the simulation,
the ﬁnal key step is to deﬁne a simulative protocol. In the
current release, BiKi supports Gromacs version 4.6.1 and
allows the minimization and equilibration protocol to be
deﬁned in full detail. Here too, a default equilibration
protocol is provided.
In the equilibration section, a stepwise protocol must
be devised by setting key parameters, such as target
temperature, thermodynamics ensemble, simulation time,
and time step. After the equilibration steps have been set
up, similar parameters must be assigned for the
production section. Additionally, the production section
has a “Run Count” ﬁeld, where the number of replicas
can be set for the production runs. This is useful when
runs are carried out in parallel to accumulate statistics. A
reset button allows the user to revert back to the default
parameters. Once the protocol has been completely
deﬁned, the user can perform the ﬁnal build: BiKi will
create speciﬁc folders for minimization, for each
equilibration step, and for the production. The user
can choose to run the simulations locally from the GUI,
to run them manually (in every step, a bash run.sh script
ﬁle is generated), or to move the root folder to another
machine. The time advancement or the status of the
simulation can be queried directly from the GUI. Run.sh
are bash scripts that, together with the simulation
execution line, contain a line to remove PBC visual
artifacts and allow an immediate visualization of the
trajectory. By the scripting interface, it is also possible to
wrap run.sh ﬁles into queue submission ﬁles for LSF,
SLURM, PBS, and SGE queue systems. Finally,
completed simulations can be rapidly restarted and
extended via command line scripts.
The analysis aspect of BiKi Basic includes: clustering, RMSD
computation, static pocket detection, and trajectory cleaning.
• Clustering. BiKi provides a multicore-CPU-optimized,
RMSD-based, k-medoids clustering algorithm.5 As input,
the algorithm uses a set of trajectories, the corresponding
atom selections, and the number of clusters (there is also
a mode where the number of clusters can be obtained
automatically). A clustering viewer that can display the
clustering graph is associated with the clustering engine.
The clustering engine saves medoids (centroids) as pdb
ﬁles. These can readily be used in other tools. For
example, we recently devised a pipeline comprising MD
and clustering to enhance virtual screening results.28 In
this regard, BiKi output is completely compatible with
the VS FLAP tool from Molecular Discovery.29
• Static pocket detection. Leveraging the interface to
NanoShaper, BiKi can compute static pockets in protein
structures. The static deﬁnition of pockets is based on
the diﬀerence between the solvent excluded volumes,
calculated via the Connolly−Richards deﬁnition, ob-
tained with two diﬀerent probe radii.23 Useful
information can be gathered from this process, including
pocket volume, surface area, and a list of solvent-exposed
atoms in each pocket.
• RMSD calculator. The suit includes a highly ﬂexible
RMSD calculator for static structures or along the MD
trajectory. The tool is extremely ﬂexible, in that the user
can deﬁne up to four atom selections for a pair of
structures: namely, one atom selection for the optimal
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alignment and one for RMSD computation per structure.
In this way, even pdb ﬁles with diﬀerent residue
numbering can be seamlessly managed. To the best of
our knowledge, this is the only available tool that
provides the user with this ﬂexibility.
Finally, BiKi implements scripting tools to customize all
commands. Everything done in the GUI can replicated by
scripting. BiKi ships several Python/Groovy scripts together
with Javadoc documentation in case the user wants to write
their own scripts. BiKi also allows an entire simulative campaign
to be set up in one command line specifying: pdb
preprocessing, box build-up, minimization/equilibration fold-
ers, and the production protocol.
Pocketron. BiKi oﬀers a dynamic pocket detection
algorithm, named Pocketron,10 that can track all the pockets
during an MD run. No a priori knowledge of the pocket
locations is needed to run the tracker. Pocketron has an analysis
counterpart that can represent the time-evolution variables,
such as the volume/surface area over time, the most
representative residues of each pocket, and an interaction
network graph, providing semiquantitative information on the
rate of dynamic interactions among the pockets. The
information on pocket dynamics, interaction, and exchange of
atoms over time can provide insights into the presence of
cryptic and transient pockets and allosteric communications
when analyzed as an ensemble.
Modules for Enhanced Sampling Simulative Proto-
cols. BiKi implements three recently developed modules for
enhanced sampling protocols, namely: BiKi Netics, an
unbinding protocol to rank ligands based on their residence
time;8,9 BiKi MD-Binding, a tool to perform fully ﬂexible
protein ligand docking;3 and BiKi Hydra, a tool to dynamically
characterize water persistency and “happiness” in binding
sites.11
■ BIKI NETICS
The BiKi Netics module aims to rank diﬀerent ligands binding
to the same target based on their residence time. It does this by
simulating the diﬀerent complexes in an MD setup where the
potential energy is scaled by a factor λ. The relative stability of
the simulated complexes is then observed and used as an
indicator of the residence-time diﬀerence. This simple
modiﬁcation, coupled with proper restraining, makes it possible
to study protein−ligand unbinding in a computationally
eﬀective albeit approximate way. Its use is facilitated by the
GUI, where the user can seamlessly select the scaling value and
the harmonic restraint. The latter is needed to avoid the
breaking of structures that the scaling could cause. The GUI
allows the user to run the simulations easily and to analyze
them statistically, as performed in ref 8.
■ BIKI MD-BINDING
MD-Binding3 is an algorithm aimed at accelerating the
simulation of the protein−ligand binding process, in order to
reach computational times that are compatible with an
industrial pipeline. This protocol involves an adaptive electro-
statics-driven steered MD simulation. MD-Binding uses an
attractive electrostatic bias to induce the occurrence of
concerted motions of the two binding partners and to
accelerate the association process. In particular, it leverages a
sophisticated adaptive steered MD protocol, which induces a
gentle approaching of the ligand toward the site. In the GUI,
the user can choose the attracting atoms on the ligand and
protein side. Additionally, the user must select a “switch-oﬀ” set
of atoms, typically one residue, to tell MD-Binding to turn oﬀ
the bias when the ligand is in its proximity. This is done to
focus the action of the bias on the climbing of the energy
barrier related to bimolecular association, while gradually
turning oﬀ the bias during the descent toward the destination
energetic basin.
MD-Binding was validated against a diverse set of complexes
of pharmaceutical interest, with promising results.3
Upon running of the simulations, an analysis tool allows
some key observables to be checked, including the following:
the distance from the switch-oﬀ residue; the values of the
collective variable; the time varying kappa in the harmonic
steered MD restraint; the RMSD (optionally) with respect to a
given reference structure during the run; and the cumulative
work.
MD-Binding setup can also be done via scripting. This
requires the execution of just one Python line to specify the
target protein, the ligand, the attracting residues, and the queue
submission system. From a technical perspective, the MD-
Binding setup via scripting is thus similar to that of a classical
docking campaign.
■ BIKI HYDRA
BiKi Hydra is designed to give a quick estimate of the
persistency of water molecules in a given region of a system,
usually in and near the binding site. BiKi Hydra works by
repelling water molecules in the desired region by applying an
external multicentered repulsion with the form of a screened
electrostatic interaction. The form of the bias is the same as that
used in the MD-Binding approach, but with opposite forces and
without time adaptivity. The ranking of water happiness is ruled
by the time persistency of the water molecules upon repulsion.
This technique was successfully applied to the A2A GPCR.11 In
rational drug design, identifying the relative propensities of
water molecules to reside in a given region of a site can be
instrumental in deciding how best to decorate a scaﬀold or
optimize the thermodynamic or kinetic properties of a
compound.
In setting up the protocol for this functionality, the user must
deﬁne the classical plain MD parameters and the repulsion
group, i.e., the site to be desolvated. This deﬁnition can be
applied with the usual VMD selection syntax. If a ligand is
present in the analyzed structure, the ligand is also included in
the desolvation group. The analysis part involves a dedicated
tool to compute the probability of ﬁnding water in a speciﬁc
location in space. This is achieved by building a volumetric grid
around the desolvated site, and counting the density along the
trajectory of water molecules. A ﬁle in OpenDX format is saved
and then visualized via VMD. Together with this ﬁle, the local
maxima of water probability are also found and can easily be
visualized in VMD.
■ CONCLUSIONS
The BiKi Life Sciences software suite was designed to achieve
several goals: (i) simplify MD setup, (ii) promote simpliﬁed
protocols with default values for industrial users using freely
available MD codes, (iii) push MD as the practical everyday
tool of choice for medicinal/computational chemists, and (iv)
make automated dynamic docking/undocking1 available for the
ﬁrst time at industry-compliant computational speeds. The tool
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was written in Java to confer maximum ﬂexibility and to allow
scripting by the native shipped interpreter in Groovy and in
Python. BiKi can prepare topologies in Amber and Gromacs
formats. As for Gromacs, it can prepare the full MD protocol in
three steps (prepare the pdb ﬁle, prepare the box, create the
simulation). Additionally, the installer allows BiKi to be used
immediately without any manual intervention/compilation. In
subsequent releases, we will improve the interface (particularly
in terms of remote HPC integration), add new functionalities,
improve interoperability among third-party tools, and include
wizards, and an in-the-GUI scripts editor and runner to provide
a completely guided software experience for the inexperienced
user.
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